Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities
Chiara F. Magnani(University of Zurich), Andrea Biondi(University of Milano-Bicocca)
Cited by 185
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
|Cancer Cell|2012|276
The Past, Present, and Future of Non-Viral CAR T Cells
|Frontiers in Immunology|2022|141
Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells
|Leukemia|2020|90
Encapsulated mesenchymal stem cells for in vivo immunomodulation
|Leukemia|2012|78